Publication and Commitment
Tiny Medical Apps (TMA) is committed to gender equality across all aspects of our organisation. This plan is published on our website and endorsed by senior leadership. As a small digital health SME we recognise that meaningful equality requires active effort rather than passive intent.
Adopted March 2026. Signed by Greg Burch and Matt Bourne, Joint CEOs.
Dedicated Resources
TMA designates responsibility for gender equality monitoring to the Joint CEOs. All recruitment, promotion and project leadership decisions are reviewed with gender balance in mind. Where specialist HR or equality expertise is required, TMA will commission external support.
Data Collection and Monitoring
TMA collects and reviews gender disaggregated data on its personnel annually, including breakdown by role level and project leadership. This data informs recruitment decisions and is reviewed at the annual company review. Current research team composition is reported transparently in project applications.
Training
All TMA staff participate in annual awareness sessions covering unconscious bias, inclusive recruitment and gender equality in the workplace. New starters receive equality and diversity onboarding materials.
Work-Life Balance
Flexible and remote working is available to all staff regardless of gender, caring responsibilities or life stage.
Gender Balance in Leadership
TMA makes active effort to ensure women are represented in leading research and project management roles. Currently 1 of 4 named researchers is a woman; TMA commits to improving this in future projects and recruitment.
Recruitment and Career Progression
Job descriptions are reviewed for gender-neutral language. Promotion criteria are applied consistently regardless of gender.
Research and Product Content
All DHP products are designed and tested for gender inclusivity, including accessibility for all user groups.
Zero Tolerance
TMA maintains a zero-tolerance policy for gender-based discrimination, harassment or violence in the workplace.
Review
This plan will be reviewed annually. Next review: March 2027.